Sign in

Research summary ·

Novel PET tracers to distinguish the nature of residual masses after the completion of chemotherapy in metastatic testicular germ cell tumours: A systematic review.

Written based on 1 research study on PubMed, searched on 15 Nov 2026.

What was studied

This review looked at new scan tracers for testicular germ cell tumours. A tracer is a substance that shows up on a PET scan. After chemotherapy, these tumours can leave lumps behind. Doctors need to know if a lump still holds live cancer. The usual scan, FDG PET, cannot always tell this apart. The team searched PubMed and Scopus up to December 2025. They took in lab studies, case reports and clinical trials. Studies only about FDG were left out.

What they found

In total, 17 studies were included. They looked at several new tracers, such as FLT, FAPI, fluciclovine and PSMA. Others were aimed at αvβ3-integrin, ghrelin or claudin-6. In lab work, αvβ3 scans helped tell mature teratoma from dead tissue. Ghrelin receptors are found at high levels in these tumours. But ghrelin tracers have so far only been tested in the lab. Claudin-6 is found at high levels in most kinds of these tumours. Early trials in people support it as a possible target.

What it means for patients

The authors think new PET tracers could improve care for these tumours. They point to αvβ3 and ghrelin tracers in particular. These might help guide choices after chemotherapy ends. The authors say this could cut down on needless treatment. It could also help shape care to each person.

Why it is not certain yet

The authors say more testing in patients is needed first. Until then, these scans are not ready for routine use. Some key results come only from lab studies. Claudin-6 has been tested only in early trials. The abstract does not say how accurate the new scans were. A review can only be as good as the studies in it.

Source

Novel PET tracers to distinguish the nature of residual masses after the completion of chemotherapy in metastatic testicular germ cell tumours: A systematic review.

PubMed · PMID 42390562

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Testicular cancer publications
Novel PET tracers to distinguish the nature of residual masses after the completion of chemotherapy in metastatic testicular germ cell tumours: A systematic review. · Testicular cancer news explained – Frontlight Research